H1 2026 Earnings
Financial report interval: 2025.12.30 - 2026.06.30
Overview: Ascentage Pharma(AAPG) the Revenue is 44.49 M (--%), Miss estimate;the EBIT is -104.13 M (--%), Miss estimate;the EPS is -0.32 (--%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.04B--
0.05B--
-0.01B--%
EBITMiss expectations
-0.10B--
-0.10B--
-0.01B--%
EPSExceed expectations
-0.32--
-0.5533--
+0.2333--%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf